ATSECARD® 100MG
ATSECARD® 100MG

Инструкция по применению

Для специалистов здравоохранения

Indications

- Primary prevention of acute myocardial infarction in the presence of risk factors (e.g., diabetes mellitus, hyperlipidemia, arterial hypertension, obesity, smoking, advanced age) and recurrent myocardial infarction.

- Unstable angina pectoris.

- Prevention of ischemic stroke (including in patients with transient cerebral circulatory failure).

- Prevention of thromboembolism after surgery and invasive vascular interventions (e.g., aortocoronary bypass, carotid endarterectomy, arterio-venous bypass, coronary angioplasty and stenting, carotid angioplasty).

- Prevention of deep vein thrombosis and thromboembolism of the pulmonary artery and its branches (including during prolonged immobilization as a result of extensive surgery).

How to use and dosage

Atsecard® tablets should be taken at least 30 minutes before a meal with plenty of water. To ensure the release of ASC in the alkaline environment of duodenum, tablets should not be broken, crushed or chewed. Atsecard® tablets are taken once a day or every other day. Acecard® is intended for long-term use. The duration of therapy is determined by a physician.

Primary prophylaxis of acute myocardial infarction in the presence of risk factors: 100 mg daily or 300 mg every other day (the first tablet should be chewed for faster absorption).

Prevention of recurrent myocardial infarction, stable and unstable angina: 100-300 mg daily.

Unstable angina pectoris (when acute myocardial infarction is suspected): the initial dose of 100-300 mg (the tablet should be broken, crushed or chewed for faster absorption) should be taken by the patient as soon as possible after the suspicion of acute myocardial infarction. A dose of 200-300 mg/day should be maintained for the next 30 days after the development of myocardial infarction. After 30 days, appropriate therapy should be administered to prevent recurrent myocardial infarction.

Prevention of ischemic stroke and transient cerebral circulation disorder: 100-300 mg/day.

Prevention of thromboembolism after surgery and invasive interventions on blood vessels: 100-300 mg per day.

Prevention of deep vein thrombosis and thromboembolism of the pulmonary artery and its branches: 100 mg daily or 300 mg every other day. Actions in case of missed intake of one or more doses of the medicinal product: take the missed tablet as soon as you remember about it and then continue taking it as usual. To avoid doubling the dose, do not take a missed tablet if the time for taking the next tablet is approaching.

Peculiarities of the drug action at first administration and at its withdrawal: No peculiarities of the drug action at first administration and at its withdrawal were observed.